Ignite Creation Date:
2024-05-05 @ 5:31 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00479167
Status:
TERMINATED
Last Update Posted:
2021-11-04
First Post:
2007-05-24
Brief Title:
A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkins Lymphoma
Sponsor:
Rush University Medical Center
Organization:
Rush University Medical Center
Organization Data
Organization:
Rush University Medical Center
Class:
OTHER
Study ID:
LYM 2005-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Rush University Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Millennium Pharmaceuticals Inc | INDUSTRY |
| GlaxoSmithKline | INDUSTRY |